|
Lenivia
|
1.5 mg
|
EU/2/25/355/009
|
Zoetis Belgium S.A., Beļģija
|
QN02BG93
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Izenivetmab, Izenivetmab
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
21-Nov-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/355/009 |
|
6 |
I tipa stikla flakons, 1 ml |
-
|
|
|
Purevax RCPCh
|
-
|
EU/2/04/050/002
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI06AJ03
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Attenuated feline rhinotracheitis herpesvirus,Inactivated feline panleucopenia virus,Attenuated Chlamydophila felis,Inactivated feline Calicivirosis antigens
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Animal Health France SCS, Francija
|
| Date of authorisation/renewal: |
23-Feb-2005
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/04/050/002 |
1 devas/flakonā |
50 |
Pudele, 1 deva |
-
|
|
|
Loxicom
|
2.5 mg
|
EU/2/08/090/024
|
Norbrook Laboratories (Ireland) Limited, Īrija
|
QM01AC06
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Norbrook Laboratories Limited, Lielbritānija
|
| Date of authorisation/renewal: |
12-Mar-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/090/024 |
2,5 mg |
2 |
Blisteris, 10 tablete |
-
|
|
|
Emepax 24 mg
|
24 mg
|
EU/2/26/363/005
|
Axience, Francija
|
QA04AD90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Maropitant citrate monohydrate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
26-Mar-2026
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/26/363/005 |
|
10 |
OPA/Al/PVH-Al blisteris, 4 tablete |
-
|
|
|
Equioxx
|
8.2 mg/g
|
EU/2/08/083/001
|
AUDEVARD , Francija
|
QM01AH90
|
horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
paste for oral use
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
23-Jun-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/083/001 |
8,2 mg/g |
1 |
Pilnšļirce, 7,32 g |
-
|
|
|
RESPIPORC FLU3
|
-
|
EU/2/09/103/003
|
Ceva Sante Animale,, Francija
|
QI09AA03
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Strains of inactivated Influenza A virus/ swine
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
IDT Biologika GmbH, Vācija
|
| Date of authorisation/renewal: |
13-Jan-2015
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/09/103/003 |
|
1 |
Stikla flakons, 100 ml |
-
|
|
|
Rimadyl
|
50 mg
|
V/I/22/0026
|
Zoetis Belgium S.A., Beļģija
|
QM01AE91
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Carprofen
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
17-Jun-2022
|
| Marketing authorisation valid until: |
16-Jun-2027
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOC] 06112024PL (06-Nov-2024)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/22/0026-01 |
|
1 |
Polietilēna pudele, 20 tablete |
[PDF]
|
|
|
NEXGARD SPECTRA
|
-
|
EU/2/14/177/001
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Milbemycin oxime,Afoxolaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
15-Feb-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/14/177/001 |
|
1 |
PVH/Aclar/Al blisteris, 1 tablete |
-
|
|
|
FRONTPRO
|
68 mg
|
EU/2/19/240/009
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QP53BE01
|
Dogs >10–25 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Afoxolaner
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
20-May-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/240/009 |
68 mg |
1 |
PVH/Aclar/Al blisteris, 1 tablete |
-
|
|
|
VarroMed
|
-
|
EU/2/16/203/002
|
BeeVital GmbH, Austrija
|
QP53AG30
|
honey bees
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
bee-hive dispersion
|
| International name (active substance): |
Formic acid,Oxalic acid dihydrate
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Lichtenheldt GmbH, Vācija;Labor L+S AG, Vācija
|
| Date of authorisation/renewal: |
04-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/16/203/002 |
|
12 |
PET/AL/PE maisiņš, 15 ml |
-
|
|
|
Advocate Spot-on šķīdums lieliem suņiem
|
-
|
EU/2/03/039/009
|
Bayer Animal Health , Vācija
|
QP54AB52
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Moxidectin,Imidacloprid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
14-Jan-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/03/039/009 |
|
3 |
Pipete, 2,5 ml |
-
|
|
|
Suvaxyn CSF Marker
|
-
|
EU/2/14/179/001
|
Zoetis Belgium S.A., Beļģija
|
QI09AD04
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Live Recombinant E2 gene deleted Bovine Viral Diarrhoea Virus containing Classical Swine Fever E2 (CP7_E2alf)
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
09-Feb-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/14/179/001 |
|
1 |
Stikla flakons, 10 deva |
-
|
|
|
NexGard
|
136.0 mg/tabl.
|
EU/2/13/159/010
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QP53BE01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Afoxolaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
MERIAL, Francija
|
| Date of authorisation/renewal: |
13-Jul-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/159/010 |
136 mg/tabl. |
1 |
PVH/Aclar/Al blisteris, 1 tablete |
-
|
|
|
Evalon
|
-
|
EU/2/16/194/001
|
Laboratorios Hipra S.A., Spānija
|
QI01AN01
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension and solvent for oral spray
|
| International name (active substance): |
Oocysts of Eimeria necatrix, strain mednec 3+8,Oocysts of Eimeria brunetti, strain roybru 3+28,Eimeria acervulina (strain RA|3+20),Eimeria maxima (strain MCK+10),Eimeria tenella (strain Rt 3+15)
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
12-Feb-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/16/194/001 |
|
1 |
Stikla pudelīte, 1000 deva |
-
|
|
|
Bravecto
|
1000 mg
|
EU/2/13/158/010
|
Intervet International B.V., Nīderlande
|
QP53BE02
|
large dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Fluralaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet GesmbH, Austrija
|
| Date of authorisation/renewal: |
13-Feb-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/158/010 |
1000 mg |
1 |
Blisteris, 1 tablete |
-
|
|
|
Vectra 3D
|
-
|
EU/2/13/156/013
|
Ceva Sante Animale, Francija
|
QP53AC54
|
medium dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Permethrin,Pyriproxyfen,Dinotefuran
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Ceva Sante Animale, Francija
|
| Date of authorisation/renewal: |
27-Aug-2018
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/156/013 |
|
6 |
Pipete, 1 deva |
-
|
|
|
Pexion
|
400 mg
|
EU/2/12/147/004
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QN03AX
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Imepitoin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
| Date of authorisation/renewal: |
21-Nov-2017
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/12/147/004 |
400 mg |
250 |
Polietilēna pudele, 1 tablete |
-
|
|
|
Emevet
|
-
|
EU/2/25/343/015
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QA04AD90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Maropitant
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
02-Jun-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/343/015 |
|
5 |
Blisteris, 10 tablete |
-
|
|
|
Syvazul BTV
|
-
|
EU/2/18/231/005
|
Laboratorios SYVA S.A.U, Spānija
|
QI04AA02
|
cattle; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated bluetongue virus, serotype 8, strain BTV-8/BEL2006/02
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
LABORATORIOS SYVA, S.A.U. , Spānija
|
| Date of authorisation/renewal: |
09-Jan-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/18/231/005 |
|
1 |
Polipropilēna flakons, 80 ml |
-
|
|
|
Cardalis
|
-
|
EU/2/12/142/004
|
Ceva Sante Animale, Francija
|
QC09BA07
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Spironolactone,Benazepril hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Ceva Sante Animale, Francija
|
| Date of authorisation/renewal: |
28-Aug-2012
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/12/142/004 |
5 mg/40 mg |
90 |
Pudelīte, 1 tablete |
-
|
|